NLRC4 Protein

NLRC4 Protein

title: NLRC4 Protein
<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>NLRC4 / IPAF</td></tr>
<tr><th>Gene</th><td>[NLRC4](/genes/nlrc4)</td></tr>
<tr><th>UniProt ID</th><td>[Q9NPP6](https://www.uniprot.org/uniprot/Q9NPP6)</td></tr>
<tr><th>PDB Structure</th><td>5NPY, 5NPT, 6B5B</td></tr>
<tr><th>Molecular Weight</th><td>1623 aa (~186 kDa)</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm</td></tr>
<tr><th>Protein Family</th><td>NLR family, NOD-like receptor family</td></tr>
<tr><th>Aliases</th><td>IPAF, CARD12, CLR17.1</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/infection" style="color:#ef9a9a">Infection</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">108 edges</a></td>
</tr>
</table>
</div>

NLRC4 Protein

Overview

Nlrc4 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

...

NLRC4 Protein

title: NLRC4 Protein
<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>NLRC4 / IPAF</td></tr>
<tr><th>Gene</th><td>[NLRC4](/genes/nlrc4)</td></tr>
<tr><th>UniProt ID</th><td>[Q9NPP6](https://www.uniprot.org/uniprot/Q9NPP6)</td></tr>
<tr><th>PDB Structure</th><td>5NPY, 5NPT, 6B5B</td></tr>
<tr><th>Molecular Weight</th><td>1623 aa (~186 kDa)</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm</td></tr>
<tr><th>Protein Family</th><td>NLR family, NOD-like receptor family</td></tr>
<tr><th>Aliases</th><td>IPAF, CARD12, CLR17.1</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/infection" style="color:#ef9a9a">Infection</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">108 edges</a></td>
</tr>
</table>
</div>

NLRC4 Protein

Overview

Nlrc4 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

NLRC4 (NLR Family CARD Domain Containing 4), also known as IPAF (ICE protease-activating factor), is a member of the NOD-like receptor (NLR) family that plays a critical role in innate immunity and inflammasome assembly[@kofoed2011]. Unlike other NLR proteins, NLRC4 directly recognizes bacterial components and forms a distinctive wheel-like inflammasome structure. Recent research has revealed that NLRC4 activation contributes to chronic neuroinflammation in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@walsh2014]. Understanding NLRC4's role in neuroinflammation offers potential therapeutic strategies for these conditions.

Structure

Domain Architecture

NLRC4 possesses a multi-domain structure essential for its function:

• Nucleotide-binding Domain (NBD/NOD) (residues 200-450): The central ATPase domain that undergoes conformational changes upon activation. This domain contains the Walker A (P-loop) and Walker B motifs characteristic of NBDs[@hu2015]
• Leucine-Rich Repeats (LRR) (residues 1200-1623): The C-terminal LRR domain is involved in ligand sensing and auto-inhibition. In the inactive state, the LRR folds back onto the NBD to maintain inactivity
• Caspase Recruitment Domain (CARD) (residues 1-90): Located at the N-terminus, this domain mediates interactions with downstream effector proteins, particularly procaspase-1
• FIIND Domain (Function to Find): Located between the NBD and LRR, this domain is critical for NLRC4 activation and oligomerization

Structural Features

Oligomerization and Wheel Formation:

• Upon activation, NLRC4 forms a characteristic wheel-like oligomeric structure[@zhang2015]
• Each NLRC4 protomer adopts an arc conformation
• The oligomer typically consists of 11-12 subunits (unlike [NLRP3](/entities/nlrp3-inflammasome) which forms specks)
• NAIP proteins nucleate NLRC4 oligomerization

Activation Mechanisms:

• Direct binding to bacterial ligands (flagellin, T3SS rod proteins)
• Interaction with NAIP co-receptors (NAIP2, NAIP5)
• Conformational changes relieve auto-inhibition

Post-Translational Modifications

• Phosphorylation: Multiple serine phosphorylation sites regulate NLRC4 activity
• Ubiquitination: Different ubiquitination patterns control activation and degradation
• SUMOylation: Modulates inflammasome assembly

Normal Function

Inflammasome Assembly

NLRC4 is a key component of the inflammasome, a multi-protein complex that activates inflammatory responses:

Pattern Recognition: NLRC4 directly recognizes bacterial flagellin and type III secretion system (T3SS) rod proteins[@lightfield2008]

NAIP Co-Reception: Works cooperatively with NAIP2 (recognizes T3SS rod) and NAIP5 (recognizes flagellin)

Oligomerization: Activated NLRC4 nucleates wheel formation

Caspase Recruitment: The CARD domain recruits procaspase-1

Inflammasome Assembly: Full inflammasome includes NLRC4, ASC, and caspase-1

Effector Functions

Cytokine Activation:

• Converts pro-IL-1β to active IL-1β
• Converts pro-IL-18 to active IL-18
• Triggers release of these cytokines via pyroptosis

Pyroptosis:

• Inflammatory programmed cell death
• Pore formation in plasma membrane
• Release of intracellular contents
• Limits pathogen spread

Host Defense:

• Critical for defense against Salmonella typhimurium
• Essential for Legionella pneumophila resistance
• Defense against other Gram-negative bacteria

Cell Type Expression

NLRC4 is primarily expressed in:

• Macrophages
• Monocytes
• Neutrophils
• Dendritic cells
• Some epithelial cells
• [Microglia](/entities/microglia) in the brain

Role in Neurodegeneration

Alzheimer's Disease

NLRC4 inflammasome activation contributes to AD pathogenesis[@heneka2013]:

Neuroinflammation:

• NLRC4 is activated in AD brain tissue
• Co-localizes with amyloid plaques
• Contributes to chronic neuroinflammation

Interaction with [Aβ](/proteins/amyloid-beta) Pathology:

• Amyloid-beta can activate NLRC4 indirectly
• Aβ triggers microglial NLRC4 inflammasome
• Creates feed-forward inflammatory loop

Therapeutic Implications:

• NLRC4 inhibitors may reduce neuroinflammation
• Targeting NLRC4 may slow disease progression

Parkinson's Disease

NLRC4 plays a role in PD through microglial activation[@gordon2016]:

Dopaminergic Neuron Loss:

• NLRC4 in substantia nigra [microglia](/cell-types/microglia-neuroinflammation)
• Contributes to chronic inflammation
• Synergizes with other inflammasomes

[α-Synuclein](/proteins/alpha-synuclein) Connection:

• α-Synuclein oligomers may activate NLRC4
• Provides link between protein aggregation and inflammation

Therapeutic Potential:

• NLRC4 inhibition may protect [neurons](/entities/neurons)
• Reduces microglial inflammatory response

Amyotrophic Lateral Sclerosis

NLRC4 is implicated in ALS pathogenesis:

Motor Neuron Inflammation:

• Detected in ALS mouse models
• Present in patient tissue samples
• Contributes to neuroinflammation

Synergy with Other Inflammasomes:

• May work with NLRP3
• Amplifies inflammatory response
• Contributes to disease progression

Therapeutic Strategies:

• Brain-penetrant NLRC4 inhibitors
• Combination with other anti-inflammatory approaches

Mechanistic Summary

Aβ / α-Synuclein / Mutant Protein → Microglial Activation
↓
NLRC4 Inflammasome Assembly
↓
Caspase-1 Activation
↓
IL-1β / IL-18 Release
↓
Chronic Neuroinflammation
↓
Neuronal Dysfunction and Death

Therapeutic Strategies

Inhibitor Development

Several approaches are being explored:

• Small Molecule Inhibitors: Target the NBD or CARD domain
• Blocking Peptides: Prevent CARD-CARD interactions
• Natural Products: Identify inhibitors from natural sources

Challenges

| Challenge | Current Approach |
|-----------|------------------|
| CNS Penetration | Develop brain-penetrant compounds |
| Specificity | Target NLRC4 specifically over NLRP3 |
| Safety | Balance inflammation control with host defense |

Combination Therapies

• NLRC4 inhibitor + NLRP3 inhibitor
• Anti-inflammatory + neuroprotective agents
• Disease-modifying + symptom-relieving

Key Research Findings

Discovery of NLRC4

The identification of NLRC4 as a flagellin receptor by Lightfield et al. (2008) established its role in bacterial defense[@lightfield2008a]. Subsequent structural studies revealed the wheel-like architecture unique to NLRC4 inflammasomes.

Neuroinflammation Link

Research by Walsh et al. (2014) demonstrated NLRC4 activation in Alzheimer's disease brain, establishing a direct link between this inflammasome and neurodegeneration[@walsh2014a].

Therapeutic Potential

Preclinical studies using NLRC4 inhibitors have shown promise in reducing neuroinflammation and protecting neurons in disease models[@coll2015].

Related Pathways

• [Inflammasome Pathway](/mechanisms/inflammasome-pathway): Overview of inflammasome biology
• [NLRP3 Inflammasome](/mechanisms/nlrp3-inflammasome): Related inflammasome
• [Neuroinflammation](/mechanisms/neuroinflammation): Brain inflammation
• [Innate Immunity](/mechanisms/innate-immune-response): Immune system mechanisms
• [Cytokine Signaling](/mechanisms/cytokine-signaling): Inflammatory cytokines

Related Pages

• [NLRC4 Gene](/genes/nlrc4): Gene-level information
• [NLRP3 Protein](/proteins/nlrp3-protein): Related inflammasome
• [Alzheimer's Disease](/diseases/alzheimers-disease): Disease context
• [Parkinson's Disease](/diseases/parkinsons-disease): Disease context
• [Amyotrophic Lateral Sclerosis (ALS](/diseases/amyotrophic-lateral-sclerosis): Disease context
• [Microglia](/cell-types/microglia): Brain immune cells
• [Inflammasome Complex](/mechanisms/inflammasome-complex): Complex structure

Overview

Nlrc4 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Nlrc4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Neurodegenerative Diseases - Overview of disease category](/diseases/neurodegeneration)
• [Cell Types - Index of cell type pages](/cell-types)